Takeda to sell select non-core assets in Latin America for $825m
Takeda Pharmaceutical has agreed to sell a portfolio of select non-core products exclusively in Latin America to Brazilian firm Hypera…
Takeda Pharmaceutical has agreed to sell a portfolio of select non-core products exclusively in Latin America to Brazilian firm Hypera…
At the European Crohn’s and Colitis Organization (ECCO) congress in Vienna, Austria, Takeda announced the subcutaneous (SC) formulation of Entyvio…
Takeda Pharmaceutical has agreed to sell a portfolio of select non-core products exclusively in Latin America to Brazilian firm Hypera Pharma for $825m. The deal…
At the European Crohn’s and Colitis Organization (ECCO) congress in Vienna, Austria, Takeda announced the subcutaneous (SC) formulation of Entyvio (vedolizumab) met its primary endpoint…
Pre-filled syringes are regarded as one of the most effective medical devices of administering medications to patients. The rapidly increasing…
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020. The new manufacturing…
Last year, there was significant focus on the pharmaceutical industry as the race for Covid-19 treatments and vaccine began. With…
OpenClinica is pleased to announce that it will be featured on public television series In Depth, showcasing its clinical trials…